Marc Schindewolf
0000-0003-4597-0759
72 papers found
Refreshing results…
The influence of heparin’s molecular weight and the incidence of delayed type hypersensitivity reactions revisited; in response to Grims et al., Br J Dermatol 2007; 157:514–17
Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry:
Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
Etiology and VTE Risk Factor Distribution in Patients with Inferior Vena Cava Thrombosis
Alternative anticoagulation with danaparoid in two pregnancies in a patient with former heparin-induced thrombocytopenia (HIT), homozygous factor V Leiden mutation, a history of venous thrombosis and recurrent pregnancy losses
Fondaparinux-related thrombocytopenia in a patient with former HIT. Response to Rota et al. (Thromb Haemost 2008; 99: 779–781)
Tolerance of fondaparinux in patients with generalized contact dermatitis to heparin
Danaparoid in der Schwangerschaft bei Heparinunverträglichkeit
Management of cutaneous type IV hypersensitivity reactions induced by heparin
Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides
Influence of blood collection techniques on platelet function
Safe anticoagulation with danaparoid in pregnancy and lactation
Missing publications? Search for publications with a matching author name.